𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of intravesical bacillus calmette-guerin (BCG) on carcinoma in situ of the bladder

✍ Scribed by Harry W. Herr; Carl M. Pinsky; Willet F. Whitmore Jr.; Herbert F. Oettgen; Myron R. Melamed

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
389 KB
Volume
51
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring intravesical bacillus Calmett
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry
✍ Robert A. Badalament; Helen Gay; Willet F. Whitmore Jr.; Harry W. Herr; William 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Simultaneous urinary flow cytometry, cytologic, and cystoscopic examinations were performed at 3-month intervals for a minimum of 1 year on 29 patients receiving intravesical bacillus Calmette-Guerin (BCG) treatment of superficial bladder carcinoma. Flow cytometry (FCM) and cytology were concordant

Pulmonary granulomata. A complication of
Pulmonary granulomata. A complication of intravesical administration of bacillus calmette-guerin for superficial bladder carcinoma
✍ Robert L. Smith; Robert F. Alexander; Conrado P. Aranda 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Intravesical administration of bacillus Calmette-Guerin (BCG) is an effective treatment for superficial carcinoma of the bladder. The authors report a pulmonary complication characterized by miliary infiltration on chest roentgenogram and caseating granulomata on lung biopsy specimens. This case and

The prognostic value of cytology and flu
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
✍ Spasenija Savic; Inti Zlobec; George N. Thalmann; Daniel Engeler; Martina Schmau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB

## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc

Intravesical 4′-epi-doxorubicin(epirubic
Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer
✍ Michael D. Melekos; Heracles S. Chionis; George S. Paranychianakis; Houssam H. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and